PMC:7558333 / 19455-19833 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T107","span":{"begin":69,"end":72},"obj":"Disease"},{"id":"T108","span":{"begin":87,"end":89},"obj":"Disease"},{"id":"T109","span":{"begin":149,"end":161},"obj":"Disease"},{"id":"T110","span":{"begin":185,"end":195},"obj":"Disease"}],"attributes":[{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0009852"},{"id":"A108","pred":"mondo_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A109","pred":"mondo_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/MONDO_0019121"},{"id":"A110","pred":"mondo_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"In conclusion, molecular techniques are now key tools for monitoring IFD, particularly IA as recently updated in the EORTC/MSG definitions, but also Pneumocystis jirovecii or mucorales infections. Here, we suggest some adaptations of the AspICU clinical algorithm to gain in sensitivity and specificity. Large multicentric data are needed to confirm this proof of concept study."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T137","span":{"begin":0,"end":196},"obj":"Sentence"},{"id":"T138","span":{"begin":197,"end":303},"obj":"Sentence"},{"id":"T139","span":{"begin":304,"end":378},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In conclusion, molecular techniques are now key tools for monitoring IFD, particularly IA as recently updated in the EORTC/MSG definitions, but also Pneumocystis jirovecii or mucorales infections. Here, we suggest some adaptations of the AspICU clinical algorithm to gain in sensitivity and specificity. Large multicentric data are needed to confirm this proof of concept study."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"436","span":{"begin":149,"end":171},"obj":"Species"},{"id":"437","span":{"begin":185,"end":195},"obj":"Disease"}],"attributes":[{"id":"A436","pred":"tao:has_database_id","subj":"436","obj":"Tax:42068"},{"id":"A437","pred":"tao:has_database_id","subj":"437","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In conclusion, molecular techniques are now key tools for monitoring IFD, particularly IA as recently updated in the EORTC/MSG definitions, but also Pneumocystis jirovecii or mucorales infections. Here, we suggest some adaptations of the AspICU clinical algorithm to gain in sensitivity and specificity. Large multicentric data are needed to confirm this proof of concept study."}